Trial Profile
Clinical study of landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Landiolol (Primary) ; Diltiazem
- Indications Atrial fibrillation; Atrial flutter
- Focus Therapeutic Use
- Acronyms JL-KNIGHT
- 23 Feb 2012 Results published in Circulation Journal.
- 16 Oct 2010 Results presented at the 2010 Annual Meeting of the American Society of Anesthesiologists
- 14 Jan 2010 Planned end date (1 Feb 2010) added University Hospital Medical Information Network - Japan record.